Skip to content
Royal Studio World

The Zimbabwean Government Turns Down ‘Lopsided’ US Health Aid Deal Because of Information Apprehensions

Health funding illustration
The offered American financial assistance was aimed at programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has declined a major American health deal valued at 367 million US dollars (272 million pounds) spanning five years over Washington's demand for sensitive information.

This move became public after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government representative has since explained that the US was seeking biological samples for scientific study and commercial gain but refused to share the benefits from future medical innovations.

"We are forced to start the difficult and regrettable process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for further dialogue to secure a deal acceptable to both sides so the country's vital HIV treatment initiative can continue.

Broader Implications

This rejection comes after a similar case in neighbouring Kenya, where a court halted a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.

Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had administered aid for the American government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.

As per reports, Sixteen nations in Africa have so far signed similar health pacts, constituting over $18.3bn in new funding.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this collaboration could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador said.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"The proposal required Zimbabwe to share its biological resources and data indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.

"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the end products would be accessible to our people if a future disease outbreak arise."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems previously set up via the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.

"This framework is intended to guarantee that when a nation provides its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."

These objections over the US deal "should not be misconstrued as anti-American sentiment," he added.

"We encourage continued discussions with our American counterparts on how subsequent co-operation could be arranged in a manner that respects the sovereignty and dignity of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but urged that negotiations need to persist given that much of the country's HIV programmes were funded by foreign aid.

"Where technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group commented.

The halted deal emphasises the ongoing tensions between receiving crucial international aid and protecting national sovereignty in an ever more interconnected world.

Written by

Mark Martinez

Award-winning photographer with over a decade of experience in visual storytelling, specializing in weddings and corporate media.

Royal Studio World

Type to search articles.